Position in ALKS
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$1,640,704
-$141,622 QoQ
Shares Held
46,400
-27.2% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ADAR1 Capital Management, LLC holds $31,391,903 across 13 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
1,000,604 | $13,908,395 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
268,391 | $8,083,936 | |
| 3 | BIOA |
BioAge Labs, Inc.
|
135,560 | $2,370,944 | |
| 4 | ALKS |
Alkermes plc.
This page
|
46,400 | $1,640,704 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
29,642 | $1,532,194 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
26,913 | $1,295,860 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
105,000 | $999,600 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
20,000 | $478,600 |
All Filings in ALKS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,640,704 | 46,400 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,782,326 | 63,700 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $1,686,000 | 56,200 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,287,450 | 45,000 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $293,006 | 10,188 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,083,323 | 74,431 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,737,505 | 196,577 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,239,162 | 156,600 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||